Immuron (IMRN) Assets Average (2016 - 2025)
Immuron (IMRN) recorded quarterly Assets Average of $3.3 million in Q3 2025, down 54.39% quarter-over-quarter from $7.2 million in Q2 2025, and down 36.67% on a YoY basis from $5.2 million in Q3 2024.
Immuron (IMRN) Assets Average (2016 - 2025) Analysis & Trends
Immuron's Assets Average history runs 10 years deep, the most recent figure standing at $3.3 million for Q3 2025.
- In Q3 2025, Assets Average fell 36.67% year-over-year to $3.3 million; the TTM figure through Sep 2025 stood at $3.3 million (down 36.67% YoY), while the FY2025 annual figure was $3.3 million, down 35.61% from the prior year.
- Assets Average was $3.3 million for Q3 2025 at Immuron, down from $7.2 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $21.5 million in Q2 2021 to a low of $3.3 million in Q3 2025.
- Historically, Assets Average has averaged $10.8 million across 5 years, with a median of $9.8 million in 2021.
- The sharpest annual moves came in 2021 and 2024: Assets Average jumped 942.92% in 2021, then tumbled 66.55% in 2024.
- A 5-year view of Assets Average shows it stood at $10.5 million in 2021, then soared by 59.94% to $16.8 million in 2022, then plunged by 56.74% to $7.3 million in 2023, then tumbled by 44.2% to $4.1 million in 2024, then fell by 18.8% to $3.3 million in 2025.
- The last three Assets Average figures came in at $3.3 million (Q3 2025), $7.2 million (Q2 2025), and $4.1 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | 3.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 3.29 Mn |
| Jun 30, 2025 | 7.22 Mn |
| Dec 31, 2024 | 4.06 Mn |
| Sep 9, 2024 | 5.20 Mn |
| Jun 30, 2024 | 5.19 Mn |
| Dec 31, 2023 | 7.27 Mn |
| Sep 28, 2023 | 13.80 Mn |
| Aug 30, 2023 | 13.94 Mn |
| Jun 30, 2023 | 15.51 Mn |
| Dec 31, 2022 | 16.81 Mn |
| Aug 31, 2022 | 17.54 Mn |
| Jun 30, 2022 | 8.99 Mn |
| Dec 31, 2021 | 10.51 Mn |
| Jun 30, 2021 | 21.52 Mn |
| Dec 31, 2020 | 25.48 Mn |
| Sep 1, 2020 | 16.40 Mn |
| Jun 30, 2020 | 2.06 Mn |
| Dec 31, 2019 | 3.03 Mn |
| Jun 30, 2019 | 6.85 Mn |
| Dec 31, 2018 | 19.26 Mn |